Verified employee & interview reviews

CK Birla Hospitals Reviews

Gurugram, Haryana

—/ 5

0 reviews

CK Birla Hospitals is a key healthcare vertical of CK Birla Healthcare Private Limited, which operates as a critical subsidiary of the highly diversified, multibillion-dollar Indian multinational conglomerate, the CKA Birla Group. Established originally under the corporate umbrella incorporated in October 2014, the healthcare division was conceptualized to fundamentally transform the provision, execution, and patient culture of medical care across India. Headquartered out of New Delhi with its registered corporate office located at the prominent Birla Tower on Barakhamba Road, the entity operates as a privately held, non-government organization focused on delivering world-class, family-centric clinical services with an emphasis on empathy, transparency, and clinical excellence. The core operations of CK Birla Healthcare are built around multi-specialty hospital facilities and highly specialized fertility clinics. Under the primary hospital banner, the company operates two major state-of-the-art facilities strategically positioned within the Delhi National Capital Region (NCR): one full-scale campus in Sector 51, Gurugram, and another premium clinical facility in Punjabi Bagh, West Delhi. These hospitals offer an extensive range of advanced therapeutic interventions across high-demand specialties including pediatrics, neonatology, joint replacements, oncology, and gastro-hepato-biliary conditions. The Punjabi Bagh facility has earned consecutive placements on the prestigious Times Health Rankings, reflecting its strong community trust and clinical adherence to global standards, including medical care frameworks adapted from the UK’s National Health Service (NHS) guidelines. Complementing its multi-specialty hospitals, the company rapidly expanded its footprint in reproductive medicine through its specialized subsidiary brand, Birla Fertility & IVF. This division delivers a comprehensive spectrum of assisted reproductive technologies, including in-vitro fertilization (IVF), intra-uterine insemination (IUI), egg freezing, and advanced male and female fertility diagnostics, managing an expanding network of over 23 centers nationwide. Financially, CK Birla Healthcare Private Limited has demonstrated robust commercial scaling within the Indian healthcare sector. For the fiscal year ending March 31, 2025, the company reported an annual operating revenue of INR 386 crore, driven by a strong compounded annual growth rate (CAGR) of 31% over the preceding year. To sustain its capital-intensive medical infrastructure and aggressive geographical expansion plans, the company maintains an authorized share capital of INR 500 crore, backed by a paid-up capital of INR 338 crore. The entity enjoys significant financial flexibility and liquidity support through its parent group, receiving corporate guarantees and regular equity infusions from established group entities such as GMMCO Limited. Operationally, the organization relies on a substantial workforce, utilizing a comprehensive team of over 1,000 healthcare, corporate, and medical professionals to manage its daily clinical activities. The company's strategic governance is led by an experienced board of directors, which includes Srinivasa Varadhan Tirumalai Echambadi, Shyam Sunder Sharma, and Akshat Seth, ensuring alignment with the CKA Birla Group's long-term legacy of trust, ethical healthcare delivery, and sustainable community development.